These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 19332798)

  • 21. Testing front-of-package warnings to discourage red meat consumption: a randomized experiment with US meat consumers.
    Taillie LS; Chauvenet C; Grummon AH; Hall MG; Waterlander W; Prestemon CE; Jaacks LM
    Int J Behav Nutr Phys Act; 2021 Sep; 18(1):114. PubMed ID: 34493289
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The variability and quality of medication container labels.
    Shrank WH; Agnew-Blais J; Choudhry NK; Wolf MS; Kesselheim AS; Avorn J; Shekelle P
    Arch Intern Med; 2007 Sep; 167(16):1760-5. PubMed ID: 17846395
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Receipt and use of spoken and written over-the-counter medicine information: insights into Australian and UK consumers' experiences.
    Tong V; Raynor DK; Aslani P
    Int J Pharm Pract; 2018 Apr; 26(2):129-137. PubMed ID: 28544204
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Organ-specific warnings; internal analgesic, antipyretic, and antirheumatic drug products for over-the-counter human use; final monograph. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2009 Apr; 74(81):19385-409. PubMed ID: 19507324
    [TBL] [Abstract][Full Text] [Related]  

  • 25. User testing as a method for identifying how consumers say they would act on information related to over-the-counter medicines.
    Tong V; Raynor DK; Aslani P
    Res Social Adm Pharm; 2017; 13(3):476-484. PubMed ID: 27423784
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human and veterinary drugs: good manufacturing practices and proposed exemptions for certain OTC products.
    Fed Regist; 1978 Sep; 43(190 Pt 2):45013-89. PubMed ID: 10316700
    [No Abstract]   [Full Text] [Related]  

  • 27. Enhancing information acquisition for over-the-counter medications by making better use of container surface space.
    Wogalter MS; Magurno AB; Dietrich DA; Scott KL
    Exp Aging Res; 1999; 25(1):27-48. PubMed ID: 11370108
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Over-the-counter analgesics in older adults: a call for improved labelling and consumer education.
    Roumie CL; Griffin MR
    Drugs Aging; 2004; 21(8):485-98. PubMed ID: 15182214
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The ability of the geriatric population to read labels on over-the-counter medication containers.
    Watanabe RK; Gilbreath K; Sakamoto CC
    J Am Optom Assoc; 1994 Jan; 65(1):32-7. PubMed ID: 8132950
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Developing consumer-centered, nonprescription drug labeling a study in acetaminophen.
    King JP; Davis TC; Bailey SC; Jacobson KL; Hedlund LA; Di Francesco L; Parker RM; Wolf MS
    Am J Prev Med; 2011 Jun; 40(6):593-8. PubMed ID: 21565649
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is Nutrient Content and Other Label Information for Prescription Prenatal Supplements Different from Nonprescription Products?
    Saldanha LG; Dwyer JT; Andrews KW; Brown LL; Costello RB; Ershow AG; Gusev PA; Hardy CJ; Pehrsson PR
    J Acad Nutr Diet; 2017 Sep; 117(9):1429-1436. PubMed ID: 28571654
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tamper-evident packaging requirements for over-the-counter human drug products--FDA. Final rule.
    Fed Regist; 1998 Nov; 63(213):59463-71. PubMed ID: 10187120
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of warning labels on reducing health halo effects of nutrient content claims on breakfast cereal packages: A mixed-measures experiment.
    Mediano Stoltze F; Busey E; Taillie LS; Dillman Carpentier FR
    Appetite; 2021 Aug; 163():105229. PubMed ID: 33789168
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pictorial Warning Labels and Memory for Cigarette Health-risk Information Over Time.
    Peters E; Shoots-Reinhard B; Evans AT; Shoben A; Klein E; Tompkins MK; Romer D; Tusler M
    Ann Behav Med; 2019 Mar; 53(4):358-371. PubMed ID: 29947729
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Analysis of over-the-counter medicines’ information and strategies oriented to the community for improving its access and quality.].
    Armando PD; Moscardó MN; Tenllado MI; Uema SAN
    Rev Fac Cien Med Univ Nac Cordoba; 2018 Dec; 75(4):248-254. PubMed ID: 30734703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 'It's all there in black and white' - or is it? Consumer perspectives on the proposed Australian Medicine Information Box over-the-counter label format.
    Tong V; Raynor DK; Aslani P
    Health Expect; 2016 Aug; 19(4):948-61. PubMed ID: 26230544
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The influence of need for cognition and principal display panel factors on over-the-counter drug facts label comprehension.
    Catlin JR; Pechmann C; Brass EP
    Health Commun; 2012; 27(3):264-72. PubMed ID: 21899401
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Using change detection to objectively evaluate whether novel over-the-counter drug labels can increase attention to critical health information among older adults.
    Harben AL; Kashy DA; Esfahanian S; Liu L; Bix L; Becker MW
    Cogn Res Princ Implic; 2021 May; 6(1):40. PubMed ID: 34041617
    [TBL] [Abstract][Full Text] [Related]  

  • 39. OTC product: maximum strength Zantac 150.
    Swanson KA
    J Am Pharm Assoc (2003); 2005; 45(4):528. PubMed ID: 16128512
    [No Abstract]   [Full Text] [Related]  

  • 40. Standardised (plain) cigarette packaging increases attention to both text-based and graphical health warnings: experimental evidence.
    Shankleman M; Sykes C; Mandeville KL; Di Costa S; Yarrow K
    Public Health; 2015 Jan; 129(1):37-42. PubMed ID: 25542740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.